CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, April 14, 2023 Centogene N.V. , the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today. | April 14, 2023
Aims to resolve patient diagnostic odyssey, often spanning years and multiple misdiagnoses before accurate diagnosisCombines cutting-edge technology and streamlined CE-IVD bioinformatics. | April 12, 2023
The global market access and expansion partnership, initially established in 2015, aims to provide an efficient and timely diagnosis to patients with Lysosomal Storage Disorders Diagnosis plays a. | April 11, 2023
By Chris Wack Centogene N.V. said Tuesday that it has extended its partnership with Takeda Pharmaceutical Co. to diagnose patients with Lysosomal Storage Disorders. Under the renewed. | April 11, 2023
Company’s launch of Biodata Network offers new portfolio of data-driven solutionsCollaboration with BC Platforms increases access to data-driven genomic insights via Global Data Partner Network,. | November 3, 2022